Pre-made Tibulizumab benchmark antibody ( Bispecific Mixed mAb and scFv, anti-TNFSF13B;IL17A/IL17 therapeutic antibody, Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4;CTLA-8/CTLA8A Antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Tibulizumab biosimilar, Bispecific Mixed mAb and scFv, Anti-TNFSF13B;IL17A/IL17 Antibody: Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4;CTLA-8/CTLA8A therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Tibulizumab is a subcutaneously administered, bispecific antibody that targets B-cell activating factor (BAFF) and interleukin-17, being developed by Eli Lilly.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-568-1mg	1mg	Inquiry
GMP-Bios-ab-568-10mg	10mg	Inquiry
GMP-Bios-ab-568-100mg	100mg	Inquiry
GMP-Bios-ab-568-xmg	＞100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Tibulizumab biosimilar, Bispecific Mixed mAb and scFv, Anti-TNFSF13B;IL17A/IL17 Antibody: Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4;CTLA-8/CTLA8A therapeutic antibody
INN Name	Tibulizumab
Target	TNFSF13B;IL17
Format	Bispecific Mixed mAb and scFv
Derivation	Bispecific antibody
Species Reactivity	Human
CH1 Isotype	IgG4
VD LC	Kappa;Kappa
Highest_Clin_Trial (Jan '20)	Phase-I
Est. Status	Discontinued
100% SI Structure	None;None
99% SI Structure	None;None
95-98% SI Structure	None;6nou:AA/6nov:AB
Year Proposed	2017
Year Recommended	2018
Companies	Eli Lilly
Conditions Approved	na
Conditions Active	na
Conditions Discontinued	Rheumatoid arthritis;Sjogren's syndrome
Development Tech	na